25 May 2023
Helping clinicians diagnose, monitor, and treat rare eye conditions
In a pioneering effort to facilitate the early diagnosis of CLN3, our Save Sight Institute researchers recently conducted a retrospective study on young patients to identify reliable biomarkers for neurological assessment and genomic investigation of this rare disease.
